The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Microsoft hasn’t signed off on OpenAI’s dramatic reversal of its onetime plan to become a for-profit venture.
The US is breaking past Mach 5 and catching up to China and Russia in futuristic, hypersonic military technology.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
President Trump wants to bring film-making back to Hollywood by imposing 100% tariffs on movies produced outside of the US.
Skechers, known for its comfortable and affordable sneakers, agreed to a $9.4 billion deal to be taken private by 3G Capital.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Future battlefields will be shaped by AI weapons that defense firms and Big Tech are vying to build for the military. Guardrails are lagging.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.